Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 1/20 | 0.34 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.32 |
| ▸ | BACE1 | P56817 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2580615 | 0.88 | ADRB2 (0.36) | ADRB2AOC3 | |
| SCHEMBL2835703 | 0.88 | ADRB2 (0.36) | ADRB2AOC3 | |
| SCHEMBL15614743 | 0.80 | ADRB2 (0.41) | ADRB2 | |
| SCHEMBL13510949 | 0.80 | ADRB2 (0.41) | ADRB2 | |
| SCHEMBL27597363 | 0.73 | ADRB2 (0.41) | ADRB2 | |
| SCHEMBL27553868 | 0.73 | ADRB2 (0.41) | ADRB2 | |
| SCHEMBL15579395 | 0.73 | CYP1A2 (0.34) | ADRB2AOC3 | |
| SCHEMBL15579394 | 0.73 | CYP1A2 (0.34) | ADRB2AOC3 | |
| SCHEMBL15579009 | 0.73 | CYP1A2 (0.34) | ADRB2AOC3 | |
| SCHEMBL2012341 | 0.73 | NFKB1 (0.41) | ADRB2AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100209508-A1 | Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction | CORUS PHARMA, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| US-20100209508-A1 | Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction | CORUS PHARMA, INC. (US) | 2010-08-19 | — | — | US | disclosed |
| US-20100209508-A1 | Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction | CORUS PHARMA, INC. (US) | 2010-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100209508-A1 | Substituted Phenylphosphates as Mutual Prodrugs of Steroids and ß-Agonists for the Treatment of Title Pulmonary Inflammation and Bronchoconstriction | ADRB1, ADRB3, ADRB2 | ADRB2 3/4885AOC3 906/4885BACE1 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.